|
?:authorAffiliation
|
-
[\'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP-CUP), F-75015, Paris, France.\', \'Centre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, and Immunology Department, Georges Pompidou European Hospital, APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, PARCC, INSERM, F-75015, and Emergency Department, APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Hematology Department, APHP-CUP, F-75014, Paris, France.\', \'Department of Automated Diagnostic Biology, Hôpital Cochin, APHP-CUP, F-75014, Paris, France.\', \'Université de Paris Imagine Institute, Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, F-75015, and Paris Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, APHP-CUP, F-75014, Paris, France.\', \'Université de Paris, Vascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation), APHP-CUP, F-75015, Paris, France.\', \'Translational Immunology Lab, Department of Immunology, Institut Pasteur, and Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, Hematology Department, APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Plastic Surgery Department, APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, PARCC, INSERM, F-75015, and Hematology Department, APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, Institut Cochin, INSERM, F-75014, Paris, France.\', \'Intensive Care Medicine, APHP-CUP, F-75014, Paris, France.\', \'Immunology Department, APHP-CUP, F-75014, Paris, France.\', \'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Anaesthesia, Intensive Care and Perioperative Medicine Department, APHP-CUP, F-75014, Paris, France.\', \'Anaesthesia, Intensive Care and Perioperative Medicine Department, APHP-CUP, F-75014, Paris, France.\', \'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Respiratory Medicine Department and Biosurgical Research Lab (Carpentier Foundation), APHP-CUP, F-75015 Paris, France and F-CRIN INNOVTE, Saint-Étienne, France.\', \'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Intensive Care Unit and Biosurgical Research Lab (Carpentier Foundation), APHP-CUP, F-75015, Paris, France.\', \'Université de Paris, Institut Cochin, INSERM, and Hematology Department, APHP-CUP, F-75014, Paris, France.\', \'Université de Paris, PARCC, INSERM U970, F-75015, and Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, APHP-CUP, F-75014, Paris, France.\', \'Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, and Hematology Department and Biosurgical Research Lab (Carpentier Foundation), APHP-CUP, F-75015 Paris, France and F-CRIN INNOVTE, Saint-Étienne, France.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}